APA (7th ed.) Citation

Michaels-Igbokwe, C., Lu, H., Winfree, K. B., Bhandari, N. R., Abhyankar, S., Fernandez, G. S., . . . Hess, L. M. (2026). Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: A patient and oncologist preference study. Leukemia & Lymphoma, 67(7), 1548. https://doi.org/10.1080/10428194.2026.2648867

Chicago Style (17th ed.) Citation

Michaels-Igbokwe, Christine, Hui Lu, Katherine B. Winfree, Naleen Raj Bhandari, Sarang Abhyankar, Gabriela S. Fernandez, Anup Das, and Lisa M. Hess. "Treatment Choice for Chronic Lymphocytic Leukemia After Covalent BTKi Therapy: A Patient and Oncologist Preference Study." Leukemia & Lymphoma 67, no. 7 (2026): 1548. https://doi.org/10.1080/10428194.2026.2648867.

MLA (9th ed.) Citation

Michaels-Igbokwe, Christine, et al. "Treatment Choice for Chronic Lymphocytic Leukemia After Covalent BTKi Therapy: A Patient and Oncologist Preference Study." Leukemia & Lymphoma, vol. 67, no. 7, 2026, p. 1548, https://doi.org/10.1080/10428194.2026.2648867.